Navigation Links
Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
Date:12/4/2007

PETACH TIKVA, Israel, December 4 /PRNewswire-FirstCall/ -- Healthcare Technologies Ltd. (NASDAQ: HCTL), announced today that an overwhelming number of its unaffiliated and voting shareholders (approximately 90%) voted in favor of the NexGen Biofuels transaction.

At the meeting, the shareholders were asked to approve the previously announced Asset Purchase Agreement with NexGen Biofuels, Inc, Mac Bioventures Inc. and Gamida for Life B.V. and the transactions contemplated thereby, as a result of which the Company's business will be in the field of renewable fuels rather than biotechnology and medical devices.

The goal is to finalize the transaction by the end of December 2007. The Closing of the transactions contemplated by the Agreement is subject to the approval of the Israeli District Court and other closing conditions. No assurance can be given that the transactions contemplated by the Agreement will close.

About Healthcare Technologies

Healthcare Technologies Ltd. through it subsidiaries and affiliates Gamidor Diagnostics (1984) Ltd., Danyel Biotech Ltd. and Savyon Diagnostics Ltd., specializes in the development, manufacturing and marketing of clinical diagnostic test kits and provides services and tools to diagnostic and biotech research professionals in laboratory and point of care sites worldwide.

About NexGen Biofuels, Inc.

NexGen is operating in the business of alternative fuels. NexGen plans to build and operate four ethanol and one biodiesel plant with production primarily within in the United States. NexGen is currently in the process of acquiring and developing its proposed plants and has not conducted any significant business operations or generated any operating
'/>"/>

SOURCE Healthcare Technologies Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - O...ny") (TSX:ONC; NASDAQ: ONCY ) announced today that...offering, the underwriters have exercised in full ...ional 637,500 units. Each unit is comprised of one...arrant, and was sold at a price of US$3.00 per uni...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte...el oral JAK2 inhibitor, SB1518, at The American So...tion in New Orleans. ,, Data will be presented ...lation trial of SB1518 detailing its safety, toler...) profile in dose levels ranging from 100 to 600 m...
(Date:12/2/2009)... The Scientist, a leading scientific...metrics’ Evolve “Intelligent” EM...dquo;Top 10 Innovations of 2009. , ...™ EMCCD camera from Photometrics ®, a ...and EMCCD cameras for the life sciences, was ranke...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlink... is available in its catalogue: ,, Industrial ...w.reportlinker.com/p0164431/Industrial-Enzymes---A...es market is an oligopoly with few strong players ...ket activities. Keen competition and commoditizati...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...Madison, Wis. - Wisconsin Gov. Jim Doyle , notin... passage of bipartisan legislation to overturn Pr...ic stem cell research, said Congressional inaction...le noted that Senate Majority Leader Bill Frist ,...tment to schedule a vote on the Stem Cell Research...
...Waukesha, Wis. - An imaging technology that holds...ive cardiac care will get its first commercial tes...e , which holds 25 patents related to hybrid imagi...n of the company,s new Discovery VCT at Brigham a...hnology is able to capture images of the heart and...
... While the lunar calendar may not agree, Memorial ... morning, millions of Americans have brushed off t...e knowledge that school will soon adjourn for the ...t three months will pose plenty of opportunity to ... the summer slide, when late nights in the office ...
Other Biology Technology:GE announces first installation of Discovery VCT 2Summer marks countdown to DEMOfall 2Summer marks countdown to DEMOfall 3
(Date:12/1/2009)..., SUNNYVALE, Calif., Dec. 1 Gestur...Release 3.0 - a turnkey, portable, plug and play i...ng, exhibits, entertainment and touring promotions...of patents in camera-enabled gesture recognition t...d entertainment systems. ,, Guaranteed for qual...
(Date:12/1/2009)...io Ohio State University cancer researchers have ... brain-tumor cells and blocks the growth of new tu...iruses designed to kill cancer cells oncolytic vi...brain tumors if they also carry a gene for a prote...in, called vasculostatin, is normally produced in ...
(Date:12/1/2009)...scientists, one from the United States, the other ...he leader of his wolf pack, on remote Ellesmere Is...al to finally find out what these "North Pole wol... the harshest areas of the world., "We first enc...id Mech, a renowned U.S. Geological Survey (USGS) ...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Tumor-attacking virus strikes with 'one-two punch' 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 1CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 2CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 3CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 4Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 1Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 3Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 485 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 185 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 285 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 385 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 4
... A recently discovered facet of the breast cancer ...ing mutation of BRCA1 to formation of large blood ...findings demonstrate that, in addition to an impai...tiation, mutation of BRCA1 is also linked to manip...h appears in the July issue of Cancer Cell, publis...
... Acting as a genetic Trojan horse, an experimental... its way into prostate cancer cells and then sprin...al cells unarmed. , The drug, developed at Duke U... material, called targeting RNA, to enter cancer c...top the expression of a protein that keeps the cel...
... Titanium dental implants coated with proteins tha...n treating tooth loss due to gum disease, research...pplied a protein onto implants that directs endoge...result was a nearly complete regeneration of lost ...dontics in MCG,s School of Dentistry. , Loss of ...
Other Biology News:Study identifies new role for breast cancer susceptibility gene 2Experimental RNA-based drug kills prostate cancer cells effectively and safely 2Protein-coated dental implants could improve bone regeneration 2
...loped for affinity capture of proteins from biolog...rfaces allow differential capture of proteins acco... chip has eight different spots, allowing side-by-...ded with a unique hydrophobic coating. Ciphergen's...
...r conventional PCR and thermal gradient applicatio...rmal cycler, which features a 96-well reaction mod...ble time, temperature, and protocol options, and b...ol. The system also includes PCR tubes, iTaq DNA p...
...loped for affinity capture of proteins from biolog...rfaces allow differential capture of proteins acco... chip has eight different spots, allowing side-by-...ded with a unique hydrophobic coating. Ciphergen's...
...ny-picking capabilities, 110-120 V, uses floating ...igonucleotides, carbohydrates, lipids, and other b...array applications. This system can also be used f... diameter and for inoculating 96- or 384-well micr...
Biology Products: